Literature DB >> 17020885

Reversed functional organization of mouse and human APOBEC3 cytidine deaminase domains.

Yoshiyuki Hakata1, Nathaniel R Landau.   

Abstract

APOBEC3 proteins comprise a multigene family of antiviral cytidine deaminases that are active against human immunodeficiency virus, simian immunodeficiency virus, endogenous retroelements. The Vif protein of lentiviruses binds to specific APOBEC3 proteins, notably A3F and A3G, to induce their degradation by proteasomes. APOBEC3 proteins are of two types, those with a single deaminase domain such as human (h)A3A and hA3C and those with two cytidine deaminase domains (CDD) such as hA3G, hA3F, hA3B and the mouse APOBEC3, mA3. In hA3G, both active sites are required for antiviral function but serve separate functions. CDD2 mediates the C to U deamination of the human immunodeficiency virus type 1 genome, whereas CDD1 binds the viral RNA to allow for virion packaging. Here we analyzed the role of the two domains in additional APOBEC3 family members. We analyzed APOBEC3 proteins in which either the critical glutamic acid residue or the Zn(2+) coordination amino acid residues in the active sites were mutated. The separation of function of the domains is maintained in hA3B and hA3F, but in the mouse protein mA3, the roles of the two domains are reversed. Deamination is mediated by CDD1, whereas encapsidation and dimerization are mediated by CDD2. Antiviral function of each of the APOBEC3 proteins was largely attributable to deaminase activity. Deaminase-independent antiviral activity of the active site mutants was minor. These findings suggest that the two active sites have different functions but that these functions can be interchanged in different APOBEC3 family members.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17020885     DOI: 10.1074/jbc.M604980200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  48 in total

Review 1.  Evolution of different antiviral strategies in wild mouse populations exposed to different gammaretroviruses.

Authors:  Christine A Kozak
Journal:  Curr Opin Virol       Date:  2013-08-28       Impact factor: 7.090

2.  The intrinsic antiretroviral factor APOBEC3B contains two enzymatically active cytidine deaminase domains.

Authors:  Hal P Bogerd; Heather L Wiegand; Brian P Doehle; Bryan R Cullen
Journal:  Virology       Date:  2007-04-16       Impact factor: 3.616

3.  Biochemical and biological studies of mouse APOBEC3.

Authors:  Smita Nair; Silvia Sanchez-Martinez; Xinhua Ji; Alan Rein
Journal:  J Virol       Date:  2014-01-22       Impact factor: 5.103

Review 4.  APOBECs and virus restriction.

Authors:  Reuben S Harris; Jaquelin P Dudley
Journal:  Virology       Date:  2015-03-26       Impact factor: 3.616

5.  D316 is critical for the enzymatic activity and HIV-1 restriction potential of human and rhesus APOBEC3B.

Authors:  Rebecca M McDougle; Judd F Hultquist; Alex C Stabell; Sara L Sawyer; Reuben S Harris
Journal:  Virology       Date:  2013-03-29       Impact factor: 3.616

6.  Nuclear Magnetic Resonance Structure of the APOBEC3B Catalytic Domain: Structural Basis for Substrate Binding and DNA Deaminase Activity.

Authors:  In-Ja L Byeon; Chang-Hyeock Byeon; Tiyun Wu; Mithun Mitra; Dustin Singer; Judith G Levin; Angela M Gronenborn
Journal:  Biochemistry       Date:  2016-05-19       Impact factor: 3.162

7.  Characterization of the Catalytic Domain of Human APOBEC3B and the Critical Structural Role for a Conserved Methionine.

Authors:  Sachini U Siriwardena; Thisari A Guruge; Ashok S Bhagwat
Journal:  J Mol Biol       Date:  2015-08-14       Impact factor: 5.469

8.  Adaptive evolution of Mus Apobec3 includes retroviral insertion and positive selection at two clusters of residues flanking the substrate groove.

Authors:  Bradley Sanville; Michael A Dolan; Kurt Wollenberg; Yuhe Yan; Carrie Martin; Man Lung Yeung; Klaus Strebel; Alicia Buckler-White; Christine A Kozak
Journal:  PLoS Pathog       Date:  2010-07-01       Impact factor: 6.823

9.  Mouse APOBEC3 restricts friend leukemia virus infection and pathogenesis in vivo.

Authors:  Eri Takeda; Sachiyo Tsuji-Kawahara; Mayumi Sakamoto; Marc-André Langlois; Michael S Neuberger; Cristina Rada; Masaaki Miyazawa
Journal:  J Virol       Date:  2008-09-10       Impact factor: 5.103

10.  APOBEC3 multimerization correlates with HIV-1 packaging and restriction activity in living cells.

Authors:  Jinhui Li; Yan Chen; Ming Li; Michael A Carpenter; Rebecca M McDougle; Elizabeth M Luengas; Patrick J Macdonald; Reuben S Harris; Joachim D Mueller
Journal:  J Mol Biol       Date:  2013-12-17       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.